Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.08 is 80% below its 5-year average of 0.42, near the low end of its 5-year range (0.08–2.93).
As of the fiscal period ended Tuesday, March 31, 2026. 48.89% below its 12-month average of 0.16.
Reported quarterly quick ratio; no daily interpolation. Q1 FY2026 (2026-03-31): 0.08.
QUICK RATIO (ACID-TEST)
0.08
QUICK RATIO (ACID-TEST) AVG TTM
0.16
QUICK RATIO (ACID-TEST) AVG 3Y
0.20
QUICK RATIO (ACID-TEST) AVG 5Y
0.42
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-48.89%
CURRENT VS 3Y AVG
-58.17%
CURRENT VS 5Y AVG
-80.29%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.83
median of 454 covered companies
CURRENT VS SECTOR MEDIAN
-97.08%
vs the sector median at left
Celularity Inc.
Market Cap
$49.50M
Quick Ratio (Acid-Test)
0.08
TTM Avg
0.16
3Y Avg
0.20
5Y Avg
0.42
Market Cap
$50.25M
Quick Ratio (Acid-Test)
1.61
TTM Avg
0.71
3Y Avg
0.60
5Y Avg
0.61
Market Cap
$50.51M
Quick Ratio (Acid-Test)
0.96
TTM Avg
1.17
3Y Avg
2.45
5Y Avg
4.99
Market Cap
$51.12M
Quick Ratio (Acid-Test)
3.89
TTM Avg
3.98
3Y Avg
6.90
5Y Avg
10.09
Market Cap
$51.23M
Quick Ratio (Acid-Test)
3.81
TTM Avg
5.31
3Y Avg
3.36
5Y Avg
3.21
Market Cap
$51.58M
Quick Ratio (Acid-Test)
4.04
TTM Avg
3.34
3Y Avg
3.69
5Y Avg
8.08
Market Cap
$46.79M
Quick Ratio (Acid-Test)
0.76
TTM Avg
2.59
3Y Avg
1.53
5Y Avg
1.04
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celularity Inc. (CELU) | $49.50M | 0.08 | 0.16 | 0.20 | 0.42 |
| biote Corp. (BTMD)vs › | $49.40M | 0.82 | 0.91 | 2.84 | 2.59 |
| Clene Inc. (CLNN)vs › | $49.96M | 3.07 | 1.20 | 1.50 | 3.41 |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | 1.61 | 0.71 | 0.60 | 0.61 |
| Apollomics, Inc. (APLM)vs › | $50.51M | 0.96 | 1.17 | 2.45 | 4.99 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 3.89 | 3.98 | 6.90 | 10.09 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 3.81 | 5.31 | 3.36 | 3.21 |
| INmune Bio, Inc. (INMB)vs › | $51.58M | 4.04 | 3.34 | 3.69 | 8.08 |
| BioStem Technologies, Inc. (BSEM)vs › | $46.79M | 0.76 | 2.59 | 1.53 | 1.04 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.95M | 3.74 | 0.21 | 0.34 | 1.39 |
Quick Ratio
0.08
Excludes inventory
Current Ratio
0.09
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-03-31 | 0.08 |
| 2025-12-31 | 0.15 |
| 2025-09-30 | 0.12 |
| 2025-06-30 | 0.19 |
| 2025-03-31 | 0.27 |
| 2024-12-31 | 0.28 |
| 2024-09-30 | 0.14 |
| 2024-06-30 | 0.22 |
| 2024-03-31 | 0.29 |
| 2023-12-31 | 0.21 |
| 2023-09-30 | 0.14 |
| 2023-06-30 | 0.19 |
| 2023-03-31 | 0.29 |
| 2022-12-31 | 0.45 |
| 2022-09-30 | 0.84 |
| 2022-06-30 | 1.54 |
| 2022-03-31 | 2.34 |
| 2021-12-31 | 1.89 |
| 2021-09-30 | 2.93 |
| 2021-06-30 | 0.62 |
| 2021-03-31 | 1.52 |
| 2020-12-31 | 2.56 |
| 2020-09-30 | 3.60 |
| 2020-06-30 | 5.34 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.63 |
| 2019-09-30 | 11.80 |
| 2019-06-30 | 7.54 |
| 2019-03-31 | 0.12 |
